Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 51, Pages E5016-E5024Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1314557110
Keywords
voltage-gated sodium channel; beta4 subunit; ProTx-II; X-ray structure; disease mutations
Categories
Funding
- National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R00NS073797]
- Human Frontier Science Program [RGY0064/2013]
- Heart and Stroke Foundation of Canada
Ask authors/readers for more resources
Voltage-gated sodium (Na-v) channels are embedded in a multicomponent membrane signaling complex that plays a crucial role in cellular excitability. Although the mechanism remains unclear, beta-subunits modify Na-v channel function and cause debilitating disorders when mutated. While investigating whether beta-subunits also influence ligand interactions, we found that beta 4 dramatically alters toxin binding to Na(v)1.2. To explore these observations further, we solved the crystal structure of the extracellular beta 4 domain and identified (58)Cys as an exposed residue that, when mutated, eliminates the influence of beta 4 on toxin pharmacology. Moreover, our results suggest the presence of a docking site that is maintained by a cysteine bridge buried within the hydrophobic core of beta 4. Disrupting this bridge by introducing a beta 1 mutation implicated in epilepsy repositions the (58)Cys-containing loop and disrupts beta 4 modulation of Na(v)1.2. Overall, the principles emerging from this work (i) help explain tissuedependent variations in Nav channel pharmacology; (ii) enable the mechanistic interpretation of beta-subunit-related disorders; and (iii) provide insights in designing molecules capable of correcting aberrant beta-subunit behavior.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available